太平洋投资管理市政收益基金2(PML)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PML 太平洋投资管理市政收益基金2

交易中 12-11 10:18:16 EST

7.61

+0.01

+0.07%

最高7.62	最低7.59	成交量13.66万
今开7.60	昨收7.60	日振幅0.38%
总市值9.54亿	流通市值5.06亿	总股本1.25亿
成交额103.90万	换手率0.21%	流通股本6,649万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PML","market":"US","secType":"STK","nameCN":"太平洋投资管理市政收益基金2","latestPrice":7.6055,"timestamp":1765466114997,"preClose":7.6005,"halted":0,"volume":136629,"delay":0,"floatShares":66493334,"shares":125467785,"eps":-0.435865,"marketStatus":"交易中","change":0.005,"latestTime":"12-11 10:18:16 EST","open":7.6,"high":7.62,"low":7.5911,"amount":1039025.835396,"amplitude":0.003802,"askPrice":7.61,"askSize":500,"bidPrice":7.6,"bidSize":4282,"shortable":3,"etf":0,"ttmEps":-0.435865,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":7.6005,"dividendRate":0.062323,"postHourTrading":{"tag":"盘后","latestPrice":7.64,"preClose":7.64,"latestTime":"16:10 EST","volume":10,"amount":76.4,"timestamp":1765401003638},"volumeRatio":2.258307},"requestUrl":"/m/hq/s/PML","defaultTab":"news","newsList":[{"id":"2495054976","title":"2024药企出海：做难而正确的事","url":"https://stock-news.laohu8.com/highlight/detail?id=2495054976","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495054976?lang=zh_cn&edition=full","pubTime":"2024-12-30 20:41","pubTimestamp":1735562466,"startTime":"0","endTime":"0","summary":"2024年，出海依然是生物医药产业的关键词。ADC、双抗药物合作交易火爆，出海数量再创新高；交易金额上限不断突破，多家药企凭借出海扭亏为盈。海外市场为生物医药产业带来了新的增量和发展方向，但走好出海之路绝非易事。近年来，创新药海外合作数量上升的同时，也有部分合作半路终止。此外，还有企业受地缘政治等因素影响，割舍或是调整海外业务。不过，好在各方都没有放弃，而是积极探索出新的道路。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412303282962268.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282962268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GSK.UK","BK1587","BK4007","BK1574","BK4231","BMS","PML","GSK","09939","02162","BK4532","NDAA","BK1161","BK1583","BK1515","ADC","BK4080","BK4588","BK4585","LU1829250122.USD"],"gpt_icon":0},{"id":"2494775148","title":"以生物医药为匙打开全球最大“隐形市场”——四川服务贸易成果加速上“新”","url":"https://stock-news.laohu8.com/highlight/detail?id=2494775148","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494775148?lang=zh_cn&edition=full","pubTime":"2024-12-27 17:39","pubTimestamp":1735292374,"startTime":"0","endTime":"0","summary":"近年来，四川省生物医药产业诞生的知识产权国际授权交易不断刷新创新药License-out（许可输出,即中国创新药对外授权许可）的金额新高。统计数据显示，2023年四川省医药健康产业实现营业收入近6000亿元，而仅以科伦博泰、百利天恒等五家医药企业的知识产权国际授权交易计算，其潜在交易总额就超200亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412273281346529.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412273281346529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1587","BK1574","BK4532","BK4588","GSK","BMS","PML","GSK.UK","02162","BK4585","BK1583","BK1161","LU1829250122.USD","BK4007"],"gpt_icon":0},{"id":"2484750961","title":"一周内官宣4笔BD交易！双抗新药赛道火爆，跨国药企砸百亿在华“扫货”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484750961","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484750961?lang=zh_cn&edition=full","pubTime":"2024-11-19 14:17","pubTimestamp":1731997033,"startTime":"0","endTime":"0","summary":"本文来源：时代财经 作者：李傲华双抗赛道日渐升温。11月18日，橙帆医药宣布与Avenzo Therapeutics达成一项全球战略合作协议，橙帆医药将授予Avenzo在全球范围内（不包括大中华区）开发、生产和商业化Nectin4/TROP2双特异性抗体偶联药物（ADC），同时保留在大中华区的相关权益。根据约定，橙帆医药可以获得5000万美元的首付...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OGXNPipjng5N0EEVqCMMar7oEn1NEUUoSMX0OgZcn7fE0AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OGXNPipjng5N0EEVqCMMar7oEn1NEUUoSMX0OgZcn7fE0AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241119A052YN00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241119A052YN00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PFS","IE00B1BXHZ80.USD","PML","LU1116320901.HKD","SG9999001176.USD","LU1934455194.USD","BK4231","ADC","BK4211","LU1934455863.HKD","BK4107","LU2023250504.SGD","SGXZ57979304.SGD","BK4007","LU1116320737.USD","SG9999014559.SGD","GSK.UK","BK4534","ITT","SG9999015341.SGD","SG9999001176.SGD","LU1057294990.SGD","09926","SG9999013999.USD","LU0965509010.AUD","LU1023059063.AUD","BK4588","L","LU1066053197.SGD","MRK","LU2112291526.USD","BK4080","BMS","LU1061106388.HKD","LU2461242641.AUD","IE0002141913.USD","LU0289739699.SGD","LU0417516571.SGD","HR","02162","LU0985320562.USD","LU0203347892.USD","GSK","IE00BJJMRZ35.SGD","LU0053671581.USD","09939","LU0266013472.USD","SG9999014542.SGD","LU0106261372.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2469545510","title":"【瑞典当局将加密货币交易所视为专业洗钱者】9月24日消息，据Cointelegraph报道，瑞典警察局和金融情报部门（F","url":"https://stock-news.laohu8.com/highlight/detail?id=2469545510","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469545510?lang=zh_cn&edition=full","pubTime":"2024-09-24 15:54","pubTimestamp":1727164484,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["COMP.USD.HKCC","159940","VBTC.AU","PML","TON.USD.HKCC","BTCW","UNI.USD.CC","AVAX.USD.CC","APT.USD.CC","TON.USD.CC","BK4588","APT.USD.HKCC","USDT.USD.CC","IBIT","GBTC","UNI.USD.HKCC","DEFI","BTCO","SNX.USD.CC","SNX.USD.HKCC","MKR.USD.CC","DOT.USD.HKCC","LDO.USD.HKCC","ATOM.USD.HKCC","MATIC.USD.CC","DOT.USD.CC","EZBC","HODL","MATIC.USD.HKCC","RNDR.USD.HKCC","BITO","BK4585","BRRR","LINK.USD.HKCC","FBTC","LTC.USD.HKCC","DYDX.USD.HKCC","AVAX.USD.HKCC","BK4594","COMP.USD.CC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pimco.com","stockEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":-0.0329},{"period":"3month","weight":0.0119},{"period":"6month","weight":0.0366},{"period":"1year","weight":-0.1228},{"period":"ytd","weight":-0.0556}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pimco Municipal Income Fund Ii作为封闭式管理投资公司，根据1940年《投资公司法》（经修订）及其相关规则和条例（\"法案\"）注册。","yearOnYearQuotes":[{"month":1,"riseRate":0.695652,"avgChangeRate":0.032113},{"month":2,"riseRate":0.391304,"avgChangeRate":-0.0086},{"month":3,"riseRate":0.434783,"avgChangeRate":-0.010793},{"month":4,"riseRate":0.565217,"avgChangeRate":-0.00322},{"month":5,"riseRate":0.608696,"avgChangeRate":0.009856},{"month":6,"riseRate":0.521739,"avgChangeRate":-0.003059},{"month":7,"riseRate":0.583333,"avgChangeRate":0.008514},{"month":8,"riseRate":0.5,"avgChangeRate":0.000414},{"month":9,"riseRate":0.541667,"avgChangeRate":-0.00521},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.030236},{"month":11,"riseRate":0.583333,"avgChangeRate":0.003332},{"month":12,"riseRate":0.583333,"avgChangeRate":-0.008796}],"exchange":"NYSE","name":"太平洋投资管理市政收益基金2","nameEN":"PIMCO Municipal Income Fund II"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"太平洋投资管理市政收益基金2(PML)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供太平洋投资管理市政收益基金2(PML)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"太平洋投资管理市政收益基金2,PML,太平洋投资管理市政收益基金2股票,太平洋投资管理市政收益基金2股票老虎,太平洋投资管理市政收益基金2股票老虎国际,太平洋投资管理市政收益基金2行情,太平洋投资管理市政收益基金2股票行情,太平洋投资管理市政收益基金2股价,太平洋投资管理市政收益基金2股市,太平洋投资管理市政收益基金2股票价格,太平洋投资管理市政收益基金2股票交易,太平洋投资管理市政收益基金2股票购买,太平洋投资管理市政收益基金2股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"太平洋投资管理市政收益基金2(PML)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供太平洋投资管理市政收益基金2(PML)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}